Practice Management News

ACP emphasized its strong opposition to restricting access to health care coverage through Medicaid based on employment status.

A single question that assessed pain catastrophizing — which researchers said was “an exaggerated negative reaction or response to pain, which may include rumination on pain, magnication of the pain experience or consequences of pain, and feelings of helplessness” — was useful in predicting risk for opioid misuse in primary care, according to data recently published in the Journal of the American Board of Family Medicine.

While the idea of huddles has been utilized in primary care among clinicians and medical assistants for some time, recent research suggests that including other medical staff also yields positive results.

In patients with hepatitis C virus infection who were receiving opioid substitutes, interferon-free drug regimens yielded better outcomes compared with regimens containing interferon, according to researchers.

Alex Azar II, President Donald J. Trump’s nominee to be the administration's second HHS secretary acknowledged that “all drug prices are too high” and said lowering them would be one of his top priorities if confirmed at a Senate Finance Committee hearing today.

Patients who took opioids and had a self-reported diagnosis of chronic joint arthritis or pain, or whose treatment included a specific ICD-9-CM code for a musculoskeletal condition, were more likely to be “highly satisfied” with their care, according to findings recently published in Annals of Family Medicine.

Physicians in the United States supported 12.6 million jobs and generated $2.3 trillion in annual economic activity in 2015, proving to be vital economic drivers for opportunity, growth and prosperity at state and national levels, according to a report recently released by the AMA.

Adaptive Biotechnologies and Microsoft have announced a partnership to develop a T-cell receptor-antigen map to assist in prompt detection and diagnosis of multiple diseases, including infectious diseases and cancers.

Opioid users who underwent a novel interim buprenorphine treatment had more illicit opioid-negative urine specimens than those who remained on a waitlist, according to findings presented at the American College of Neuropharmacology Annual Meeting.

The CMS recently launched a web-based program that eligible clinicians can use to provide 2017 performance data required under the Medicare Access and CHIP Reauthorization Act of 2015, according to a press release.